DCM
KERX

DAFNA Capital Management’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

DAFNA Capital Management’s Portfolio KERX Stock Details KERX Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
2015
Q1 		$443K Buy
2014
Q3 		– Sell
2014
Q2 		$1.42M Sell
2014
Q1 		$1.7M Buy
2013
Q4 		$570K Sell
2013
Q3 		$748K Sell
2013
Q2 		$575K Buy